celastrol

heat shock protein 90 alpha family class A member 1 ; Homo sapiens







39 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35107368 p17-Modulated Hsp90/Cdc37 Complex Governs Oncolytic Avian Reovirus Replication by Chaperoning p17, Which Promotes Viral Protein Synthesis and Accumulation of Viral Proteins σC and σA in Viral Factories. 2022 Mar 23 1
2 35238566 Discovery of Novel Celastrol-Imidazole Derivatives with Anticancer Activity In Vitro and In Vivo. 2022 Mar 24 3
3 33845380 Discovery of novel celastrol-triazole derivatives with Hsp90-Cdc37 disruption to induce tumor cell apoptosis. 2021 Jun 1
4 34170694 Synthesis and Biological Evaluation of Celastrol Derivatives with Improved Cytotoxic Selectivity and Antitumor Activities. 2021 Jul 23 2
5 32222543 Proteostasis regulators as potential rescuers of PMM2 activity. 2020 Jul 1 3
6 31051401 Design, synthesis and antitumor evaluation of novel celastrol derivatives. 2019 Jul 15 1
7 31725288 Discovery of Novel Celastrol Derivatives as Hsp90-Cdc37 Interaction Disruptors with Antitumor Activity. 2019 Dec 12 5
8 29274099 Effects of celastrol on Tau hyperphosphorylation and expression of HSF-1 and HSP70 in SH-SY5Y neuroblastoma cells induced by amyloid-β peptides. 2018 May 1
9 29534015 Targeting Hodgkin and Reed-Sternberg Cells with an Inhibitor of Heat-Shock Protein 90: Molecular Pathways of Response and Potential Mechanisms of Resistance. 2018 Mar 13 1
10 30316059 Discovery of novel NO-releasing celastrol derivatives with Hsp90 inhibition and cytotoxic activities. 2018 Dec 5 1
11 30588010 Celastrol induces ubiquitin-dependent degradation of mTOR in breast cancer cells. 2018 2
12 27235383 Exosomal formulation enhances therapeutic response of celastrol against lung cancer. 2016 Aug 2
13 27398312 Mutations Y493G and K546D in human HSP90 disrupt binding of celastrol and reduce interaction with Cdc37. 2016 Jul 12
14 27647369 Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties. 2016 Nov 1 3
15 25989799 Withaferin A Regulates LRRK2 Levels by Interfering with the Hsp90- Cdc37 Chaperone Complex. 2015 1
16 26227505 Hsp90 Activity Modulation by Plant Secondary Metabolites. 2015 Sep 1
17 26391399 Disruption of Heat Shock Protein 90 (Hsp90)-Protein Kinase Cδ (PKCδ) Interaction by (-)-Maackiain Suppresses Histamine H1 Receptor Gene Transcription in HeLa Cells. 2015 Nov 6 1
18 26447544 Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. 2015 Oct 20 1
19 24265268 IP-FCM platform detects the existence and regulator-caused dissociation of components in naturally assembled HSP90 complex. 2014 Apr 1
20 24351928 Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones. 2014 Jan 7 2
21 24713615 Alteration of the proteostasis network of plant cells promotes the post-endoplasmic reticulum trafficking of recombinant mutant (L444P) human β-glucocerebrosidase. 2014 2
22 24810052 Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells. 2014 May 8 2
23 24954307 The effect of celastrol, a triterpene with antitumorigenic activity, on conformational and functional aspects of the human 90kDa heat shock protein Hsp90α, a chaperone implicated in the stabilization of the tumor phenotype. 2014 Oct 9
24 24056254 Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening. 2013 Nov 1
25 21866552 Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. 2012 May 2
26 21088503 Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers. 2011 Jan 15 2
27 21129982 A systematic protocol for the characterization of Hsp90 modulators. 2011 Jan 1 1
28 21249311 Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90. 2011 Mar 4
29 21569548 Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. 2011 May 14 3
30 22087583 Remarkable stereospecific conjugate additions to the Hsp90 inhibitor celastrol. 2011 Dec 14 2
31 19996313 Celastrol inhibits Hsp90 chaperoning of steroid receptors by inducing fibrillization of the Co-chaperone p23. 2010 Feb 5 2
32 20007406 Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines. 2010 Mar 4
33 20226165 Celastrol: Molecular targets of Thunder God Vine. 2010 Apr 9 1
34 20398364 HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way. 2010 Apr 16 3
35 20480272 Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way. 2010 Nov 8
36 19585625 Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. 2009 1
37 19858214 Characterization of celastrol to inhibit hsp90 and cdc37 interaction. 2009 Dec 18 7
38 19138996 Heat shock protein 90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation. 2008 Nov 3
39 17010675 Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. 2006 Oct 2